Cargando…
Suppression of F(ENO) with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?
F(ENO) suppression testing is practical and feasible during assessment for biologics in severe asthma. Patients with significant F(ENO) suppression were less likely to be recommended biologics but saw similar reductions in exacerbation frequency. http://bit.ly/35oSoxP
Autores principales: | Faruqi, Shoaib, Zhou, Sean, Thompson, Joanne, Robinson, Terry, Watkins, Karen, Cummings, Helena, Jackson, Nicola, Prakash, Anoop, Crooks, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876132/ https://www.ncbi.nlm.nih.gov/pubmed/31777751 http://dx.doi.org/10.1183/23120541.00123-2019 |
Ejemplares similares
-
It is time to end our love affair with short-acting β(2)-agonists in asthma
por: Crooks, Michael G., et al.
Publicado: (2022) -
Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019) -
COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial
Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020) -
Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019) -
Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005)